{
  "docId": "019dd923-5de0-76bd-a169-83187257f35b",
  "docSlug": "5d146414b5cc38c9",
  "documentTitle": "Vaccines & Therapeutics Outlook Part I: Timelines and Success Factors",
  "authorId": "BCG",
  "authorName": "BCG",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 18,
  "pageCount": 34,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "data_table",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 15,
  "notes": "The slide includes a stacked bar chart showing 314 total treatments across 5 phases, and a comparison table for 4 drugs.",
  "elementsJson": [
    "headline_text",
    "bar_chart_stacked",
    "comparison_table",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5de0-76bd-a169-83187257f35b/18",
  "deckHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b",
  "deckJsonHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b.json",
  "deckAnchorHref": "/decks/019dd923-5de0-76bd-a169-83187257f35b#slide-18",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Challenges to accelerated approvals include establishing proof of efficacy with manageable systemic events and ensuring broad clinical trials with randomly assigned participants.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-fefb-728e-ad96-a0817af8d6b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.2,
        "x": 0.05,
        "y": 0.15
      },
      "kind": "chart",
      "text": "300+ treatments undergoing trials",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0545359-f83e-4208-8b20-74c07b8505cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Clinical trial phase: 314",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-fefb-728e-ad96-a6bc05e6e9e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.68,
        "x": 0.28,
        "y": 0.75
      },
      "kind": "paragraph",
      "text": "Challenges to accelerated approvals: Establishing proof of efficacy with manageable systemic events; Ensuring broad clinical trials with randomly assigned participants.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c212e43-8f1d-4f7a-9aa1-fcae0b1c58da",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "1. Emergency Use Authorization; 2. 7-day mortality rate; ... Source: ClinicalTrials.gov, Milken Institute, WHO, NEJM, RAPS, CNN, The New York Times, Company Websites, BCG",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "69741991-4286-474a-92b9-5bd69d9c87c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.68,
        "x": 0.28,
        "y": 0.25
      },
      "kind": "table",
      "text": "Comparison of 4 therapeutic candidates: Remdesivir, Plasma Therapy, Dexamethasone, Favipiravir across metrics like recovery time, mortality, availability, and EUA status.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb5b45da-71c0-4a35-9c91-7d5aae07b022",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.75,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Therapeutics | Effective therapeutic treatments could reduce the strain on healthcare systems; two candidates currently under EUA in the US",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e2a12997-fb9c-4c12-8829-09c1a6b625ed",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "019dd95a-163f-72bd-8a09-588c4fd13ad4",
      "evidence": "Title states reduction in healthcare strain + 2 candidates under EUA.",
      "confidence": 80
    },
    {
      "name": "Small Multiples",
      "slug": "small-multiples",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "019dd95a-163f-72bd-8a09-5dbed0a8410e",
      "evidence": "Repeated rows comparing therapeutics across same dimensions.",
      "confidence": 65
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 30,
      "from": 18,
      "beatId": "019dd95a-0702-74a3-87e3-b0151d6fa4d2",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Therapeutics, scenario fork, de-averaged econ indicators by country/sector",
      "position": 4,
      "confidence": 78,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    },
    {
      "to": 19,
      "from": 15,
      "beatId": "019dd95a-0702-74a3-87e3-bed022269a97",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Implications (So What)",
      "beatSlug": "triple-take-the-implications-so-what",
      "evidence": "Key success factors, efficacy priorities, scenarios",
      "position": 2,
      "confidence": 65,
      "parentBeatName": "Reflection",
      "parentBeatSlug": "reflection"
    }
  ],
  "loops": [
    {
      "to": 19,
      "from": 17,
      "name": "Scenario Fork",
      "slug": "35-scenario-fork",
      "bestFor": "Strategic planning, risk analysis, board presentations",
      "matchId": "019dd95a-088c-724c-b30f-c66c12b1ec8c",
      "evidence": "p19 plots Scenario X/1/2/3 grid; p17-18 feed the inputs.",
      "position": 5,
      "objective": "Show manufacturing readiness, therapeutics, and scenario implications for leaders",
      "structure": "The Decision Point -> Scenario A (If X) -> Scenario B (If Y) -> Scenario C (If Z) -> Recommendation",
      "confidence": 72,
      "description": "Present multiple futures based on different assumptions or decisions"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}